Long-term bone marrow culture data are the most powerful predictor of peripheral blood progenitor cell mobilization in healthy donors

Haematologica

Volumn 90, Issue 3, 2005, Pages 353-359

  López Holgado, Natalia ^a   Pata, Carmen ^a   Villarón, Eva ^a   Sánchez Guijo, Fermín ^a   Alberca, Mercedes ^a   Martín, Alejandro ^b   Corral, Mercedes ^a   Sánchez Abarca, Ignacio ^a   Pérez Simón, Josè Antonio ^a   San Miguel, Jesús Fernando ^a   Del Cañizo, Maria Consuelo ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b HOSPITAL VIRGEN DE LA CONCHA   (Spain)

Author keywords

CD34+ cells; Healthy donors; Hematopoietic progenitor cells; Long term bone marrow cultures; Mobilization

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; BLOOD DONOR; BONE MARROW CELL; BONE MARROW CULTURE; BURST FORMING UNIT E; COLONY FORMATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; LEUKAPHERESIS; MALE; NORMAL HUMAN; PERIPHERAL BLOOD STEM CELL; STEM CELL MOBILIZATION;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD34; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; CHILD; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; LEUKAPHERESIS; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROSPECTIVE STUDIES; TISSUE DONORS;

EID: 20144363432     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Gratwohl A, Passweg J, Baldomero H, Hermans J. Blood and marrow transplant activity in Europe 1997. Bone Marrow Transplant 1999;24:231-46.
2. Przepiorka D, Anderlini P, Ippoliti C, Khouri I, Fietz T, Thall P, et al. Allogeneic blood stem cell transplantation in advanced hematologic cancers. Bone Marrow transplant 1997;19:455-60.
3. Bensinger WI, Clift R, Martin P, Appelbaum FR, Demirer T, Gooley T, et al. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation. Blood 1996;88:2794-800.
4. Theilgaard-Monch K, Raaschou-Jensen K, Heilmann C, Andersen H, Bock J, Russel CA, et al. Single leukapheresis products collected from healthy donors after the administration of granulocyte colony-stimulating factor contain ten fold higher numbers of long-term reconstituting hematopoietic progenitor cells than conventional bone marrow allografts. Bone Marrow Transplant 1999;23:243-9.
5. Glimm H, Eisterer W, Lee K, Cashman J, Holyoake TL, Nicolini F, et al. Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-b2 microglobulin-null mice. J Clin Invest 2001;107:199-206.
6. Grigg AP, Roberts AW, Raunow H, Houghton S, Layton JE, Boyd AW, et al. Optimizing dose and schedule of filgastrim (granulocyte-colony stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers. Blood 1995; 86:4437-45.
7. Anderlini P, Przepiorka D, Seong C. Factors affecting mobilization of CD34+ cells in normal donors treated with filgastrim. Transfusion 1997;37: 507-12.
8. de la Rubia J, Arbona C, de Arriba F, del Cañizo C, Brunet S, Zamora C, et al. Analysis of factors associated with a low preripheral blood progenitor cell collection in normal donors transfusion. Transfusión 2002;42:4-9.
9. Engelhardt M, Bertz H, Wäsch R, Finke J. Analysis of stem cell apheresis products using intermediate-dose filgrastrtim plus large volume apheresis for allogeneic transplantation. Ann Hematol 2001;80:201-8.
10. Engelhardt M, Bertz H, Afting M, Waller CF, Finke J. High versus standard-dose filgrastim (rhG-CSF) for mobilization of peripheral-blood progenitor cells from allogeneic donors and CD34+ immunoselection. J Clin Oncol 1999;17:2160-72.
11. Engelhardt M, Winkler J, Waller C, Lange W, Mertelsmann R, Henschler R. Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin's lymphoma patients after combination chemotherapy and G-CSF. Bone Marrow Transplant 1997;19:529-37.
12. Waller CF, Bertz H, Wenger MK, Fetscher S, Hardung M, Engelhardt M, et al. Mobilization of peripheral blood progenitor cells for allogeneic transplantation: efficacy and toxicity of a high-dose rhG-CSF regimen. Bone Marrow Transplant 1996;18:279-83.
13. Fruehauf S, Schmitt K, Veldwijk MR, Topaly J, Benner A, Zellew J, et al. Peripheral blood progenitor cell (PBPC) counts during steady-state haemopoiesis enable the estimation of the yield of mobilized FBPC after granulocyte colony-stimulating factor supported cytotoxic chemotherapy: an update on 100 patients. Br J Haematol 1999;105:786-94.
14. Perez-Simon JA, Caballero MD, Corral M, Nieto MJ, Orfao A, Vazquez L, et al. Minimal number of circulating CD34+ cells to ensure successful leukapheresis and engraftment in autologous peripheral blood progenitor cell transplantation. Transfusion 1998;38:385-91.
15. del Cañizo MC, Lopez N, Vazquez L, Fernandez ME, Ana B, Caballero MD, et al. Haematopoietic damage persists one year after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1999;23:901-5.
16. Pike BL, Robinson WA. Human bone marrow colony growth in vitro. J Cell Physiol 1970;76:77-84.
17. Iscove NN, Sieber F, Winterhalter KH. Erythroid colony formation in cultures of mouse and human bone marrow: analysis of the requirements for erythropoietin by gel filtration and affinity chromatography on agarose-concavalina A. J Cell Physiol 1974;83:309-20.
18. Fauser AA, Messner HA. Identification of megakaryocytes, macrophages and eosinophils in colonies of human bone marrow containing neutrophilic, granulocytes and erythroblast. Blood 1979; 53:1023-7.
19. Lanza F, Campioni D, Moretti S, Dominici M, Punturieri M, Focarile E, et al. CD34+ subsets and long-term culture colony-forming cells evaluated on both autologous and normal bone marrow stroma predict long-term hematopoietic engraftment in patients undergoing autologous peripheral blod stem cell transplantation. Exp Hematol 2001;29:1481-93.
20. Suzuki T, Muroi K, Amemiya Y, Miura Y. Analysis of peripheral blood CD34+ cells mobilized with granulocyte colony-stimulating factor (G-CSF) using a long-term culture system. Bone Marrow Transplant 1998;21:751-7.
21. Hörner S, Pasternak G, Hehlmann. A statistically significant sex difference in the number of colony-forming cells from human peripheral blood. Ann Hematol 1997;74:259-63.
22. Carlo-Stella C, Cesana C, Regazzi E, Falzetti F, Aversa F, Rizzoli V, et al. Peripheral blood progenitor cell mobilisation in healthy donors receiving recombinant human granulocyte colony-stimulating factor. Exp Hematol 2000;28:216-24.
23. Ho AD, Young D, Maruyama M, Law P, Corringham RE, Mason JR, et al. Pluripotent and lineage-committed CD34+ subsets in leukapheresis products mobilized by rhG-CSF, GM-CSF vs a combination of both. Exp Hematol 1996;24:1460-8.
24. Miflin G, Charley C, Stainer C, Anderson S, Hunter A, Russell N. Stem cell mobilization in normal donors for allogeneic transplantation: analysis of safety and factors affecting efficacy. Br J Haematol 1996;95:345-8.
25. Chatta GS, Price TH, Allen RC, Dale DC. Effects of in vivo recombinant methionyl human granulocyte colony-stimulating factor on the neutrophil response and peripheral blood colony-forming cells in healthy young and elderly adult volunteers. Blood 1994; 84:2923-9.
26. van Hennik PB, Breems DA, Kusadasi N, Slaper-Cortenbach ICM, den Berg HV, van der Lelie HJ, et al. Stroma supported progenitor production as a prognostic tool for graft failure following autologous stem cell transplantation. Br J Haematol 2000;111:674.